Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway-Reference-Cited by-同舟云学术

Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway

Published:2004-10 Issue:3 Volume:502 Page:169-183
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Chang Gee-Chen,Hsu Shih-Lan,Tsai Jia-Rong,Wu Wen-Jun,Chen Chih-Yi,Sheu Gwo-Tarng

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage;Achanta;Cancer Res.,2001

2. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats;Aikawa;J. Clin. Invest.,1997

3. Role of NF-kB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death;Arlt;Oncogene,2003

4. Apoptosis control by death and decoy receptors;Ashkenazi;Curr. Opin. Cell Biol.,1999

5. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53;Bacus;Oncogene,2001

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of cynomolgus monkey airway, liver ductal, and kidney organoids with pharmacokinetic functions;Organs-on-a-Chip;2023-12

2. Targeted silencing of TEM8 suppresses non‑small cell lung cancer tumor growth via the ERK/Bcl‑2 signaling pathway;Molecular Medicine Reports;2021-06-22

3. Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K−AKT Signaling Pathway;Anticancer Research;2018-03-01

4. Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis;Cell Death Discovery;2018-02-14

5. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p;Molecular Cancer;2017-07-25